ALFYX
Price
$24.49
Change
+$0.56 (+2.34%)
Updated
Apr 24 closing price
Net Assets
525.69M
VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
Ad is loading...

ALFYX vs VEXRX

Header iconALFYX vs VEXRX Comparison
Open Charts ALFYX vs VEXRXBanner chart's image
Lord Abbett Alpha Strategy I
Price$24.49
Change+$0.56 (+2.34%)
VolumeN/A
Net Assets525.69M
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
ALFYX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ALFYX vs. VEXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALFYX is a Hold and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. ALFYX (526M). VEXRX pays higher dividends than ALFYX: VEXRX (0.56) vs ALFYX (0.38). ALFYX was incepted earlier than VEXRX: ALFYX (21 years) vs VEXRX (23 years). ALFYX (1.22) is less costly to investors than VEXRX (0.34). VEXRX is a more actively managed with annual turnover of: 35.00 vs. ALFYX (1.00). VEXRX has a lower initial minimum investment than ALFYX: VEXRX (50000) vs ALFYX (1000000). ALFYX annual gain was more profitable for investors over the last year : -3.77 vs. VEXRX (-12.82). ALFYX return over 5 years is better than : 36.63 vs. VEXRX (15.80).
ALFYXVEXRXALFYX / VEXRX
Total Expense Ratio1.220.34359%
Annual Report Gross Expense Ratio1.220.34359%
Fund Existence21 years23 years-
Gain YTD-12.786-14.72287%
Front LoadN/AN/A-
Min. Initial Investment1000000500002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets526M19.8B3%
Annual Yield % from dividends0.380.5667%
Returns for 1 year-3.77-12.8229%
Returns for 3 years-4.16-9.4044%
Returns for 5 years36.6315.80232%
Returns for 10 years-23.43-1.761,328%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF